<DOC>
	<DOCNO>NCT02757937</DOCNO>
	<brief_summary>Diabetes one common chronic illness among adult United States . Internet-based intervention health promotion websites patient Type 2 Diabetes typically low-cost , easily accessible , attractive . The purpose study determine whether participant ' utilization health &amp; wellness website focus diabetes self-management increase participant ' self-reported self-efficacy toward manage Type 2 Diabetes behavior change self-reported medication adherence compare standard care .</brief_summary>
	<brief_title>Reaching Better Health Study : A Website Improve Type 2 Diabetes Self-Management</brief_title>
	<detailed_description>Diabetes one common chronic illness among adult United States . Merck &amp; Co. , Inc. produce innovative website engage adult patient chronic illness self-management medication adherence . Internet-based intervention health promotion websites patient typically low-cost , easily accessible , attractive . However , grow need improve measurement , implementation evaluation online health intervention ensure patient engagement produce significant behavior change impact patient ' health long term . The primary objective study determine whether utilization health wellness website increase participant ' self-reported self-efficacy toward manage Type 2 Diabetes behavior change self-reported medication adherence . This study comprise randomize controlled trial utilize website self-management support intervention . There interventional medical treatment , change patient ' medical care . In collaboration University Pennsylvania , potential participant identify recruited Penn Medicine outpatient population base specific inclusion/exclusion criterion . Participants remain study 9 month . Participants randomly assign intervention control condition ( exposure ) . Those intervention arm access health &amp; wellness website nine month post enrollment . Online survey deliver nine month period . Primary outcomes baseline-to-two month baseline-to-4 month change diabetes management self-efficacy score measure Diabetes Self-Efficacy Scale .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Patient current patient Penn Medicine outpatient healthcare system Patient 's Primary Care Physician ( PCP ) Endocrinologist Penn Medicine provider Patient 12 month history healthcare utilization Penn Medicine system ( inoffice PCP/endocrinologist visit ) Patient complete data ( ICD10 code Type 2 diabetes diagnosis , date diagnosis , name mail address information ) Penn Data Warehouse Patient diagnose Type II Diabetes indicate ICD10 Codes : E11 . ** ( include newly diagnose ) Patients ' HbA1c â‰¥8.0 % last 6 month ( one A1c result present record , recent measurement assess ) Patient read understand English well enough complete study task . Patient regular access telephone Patient least biweekly access internet email Patient agree release medical record information Children 's Hospital Philadelphia research team Patient decease Patient indicate `` Do Not Solicit Research '' medical record Patient le 18 year age Patient old 75 year old Patient use insulin pump injectable insulin treat/manage diabetes . Patient nonEnglish speaking Patient HbA1c % chart last 6 month Patients ' HbA1c last 6 month &lt; 8.0 % Patient currently take medication raise glucose level , steroid Patient history cognitive disorder , mental illness , and/or cognitive impairment may impact ability use online website , include , dementia , Alzheimer 's disease , Parkinson 's disease , traumatic brain head injury , psychosis Patient history Heart Failure ( include Chronic Heart Disease , Chronic Heart Failure ) and/or Chronic Kidney Disease , serious cardiovascular condition ( e.g , heart attack stroke ) last 6 month Patient history endocrine gland cancer pancreatic cancer Patient undergo chemotherapy immunotherapy treatment last 6 month Patient 's medical record contain ICD10 Code Type I diabetes diagnosis . Patient 's medical record contain ICD10 Code pregnancyrelated diabetes : 024.419 ( gestational diabetes ) 024.419 ( antepartum gestational diabetes ) Z79.4 ( type II long term insulin use ) 024.91x ( pregnant woman diabetic ) Patient Prediabetic borderline Type 2 diabetic Patient pregnant lactate Patient 's electronic medical history data available Penn Medicine 's electronic medical record and/or complete Penn Data Store Patients , opinion Investigator , may noncompliant study schedule procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Medication Adherence</keyword>
	<keyword>Self-efficacy</keyword>
	<keyword>Behavior</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Diabetes Mellitus</keyword>
</DOC>